Investor profile
Evonik Venture Capital GmbH has backed 8 European tech companies across 12 funding rounds between 2015 and 2024, joining rounds totalling €189M. Most active in Healthtech and Energy. Data as of 6 Aug 2026.
Also recorded as: Evonik
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Strohm | Netherlands | 3 | €59M |
| Vivasure Medical | Ireland | 2 | €38M |
| Abolis Biotechnologies | France | 1 | €35M |
| In Ovo | Netherlands | 1 | €34M |
| HPNow | Denmark |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Abolis Biotechnologies | Other | €35M | 2024-09 |
| In Ovo | Series B | €34M | 2022-03 |
| Strohm | Other | €30M | 2024-07 |
| Vivasure Medical |
| 2 |
| €14M |
| Algal Scientific | UK | 1 | €6.2M |
| CASTOR | Israel | 1 | €3.0M |
| NumaFerm | Germany | 1 | €0 |
| Other |
| €22M |
| 2022-05 |
| Vivasure Medical | Series C | €16M | 2016-09 |
| Strohm | Other | €15M | 2022-12 |
| HPNow | Other | €14M | 2023-09 |
| Strohm | Other | €14M | 2022-08 |
| Algal Scientific | Series B | €6.2M | 2015-03 |
| CASTOR | Seed | €3.0M | 2021-08 |
